長汽(02333.HK):加大拓展海外市場 同時向新能源車和轎車作多元化發展
長汽(02333.HK)投資者關係經理李紅強在電話會議表示,在今年推出更多車型的情況下,預期今年銷量會超越過去訂下之121萬之目標,同時公司亦將加大海外市場的發展,其中包括去年新收購的泰國工廠,預期會於今年第二或第三季度起投產,並助進入更多其他如東盟等地區市場。
他指,過去在三大平台發展投入200億元人民幣,未來會繼續推進其他研發,特別是在互動駕駛、智能網聯方面,而且公司沒有就投資設限。
投資者關係總監鮑小丹指,目前中國SUV市場確實存在量大的問題,公司今後亦會作策略調整,包括發展新能源車和轎車等多元化方向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.